Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects suffering from systemic sclerosis with at least an ulcerative lesion on the fingers of the upper limbs;~* The ulcer must not present bone or tendon exposure;~* Chronicity of the lesion: at least 4 weeks;~* Men and women aged ≥ 18 years;~* The patient must be able to understand the purposes of the clinical trial and provide informed consent in writing.~Exclusion Criteria:~* Patients who are participating in other clinical trials with drug or medical device;~* Patients with a history of self-harm who can voluntarily alter the course of healing;~* Women who are pregnant or breastfeeding1;~* Patients who participated in a clinical study on the healing of skin ulcers during the previous month;~* Patients who are unable to understand the purposes and objectives of the study;~* Presence of infectious signs according to IDSA criteria at the time of recruitment;~* Presence of peripheral vascular obstructive diseases;~* Patients with psychiatric disorders;~* Patients with neoplasia;~* Patients with pathologies that induce skin photosensitivity;~* Patients with a limited life expectancy.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: ACTIVE_COMPARATOR): To the Control Group is administered the current standard therapy for 16 weeks.
- EmoLED Group (Type: EXPERIMENTAL): The treatment with EmoLED will be carried out once a week in correspondence with the dressing change of the lesion, for sixteen consecutive weeks, for a total of 16 treatments.

Based on this trial design, predict the completion outcome and termination type (if applicable).